R2* relaxometry analysis for mapping of white matter alteration in Parkinson's disease with mild cognitive impairment

Hirohito Kan1, Yuto Uchida2, Yoshino Ueki3

  • 1Department of Integrated Health Sciences, Nagoya University Graduate School of Medicine, Japan; Department of Radiology, Nagoya City University, Graduate School of Medical Sciences, Japan.

Neuroimage. Clinical
|January 8, 2022
PubMed
Abstract

Insights

White matter changes in Parkinson's disease (PD) are linked to cognitive decline. R2* relaxometry revealed microstructural alterations in white matter, potentially aiding early detection of cognitive impairment in PD patients.

Area of Science:

  • Neuroimaging
  • Neuroscience
  • Biomedical Engineering

Background:

  • Parkinson's disease (PD) is associated with white matter (WM) microstructural changes.
  • Cognitive impairment is a common non-motor symptom in PD.
  • R2* relaxometry and quantitative susceptibility mapping (QSM) offer sensitive measures of WM integrity and iron deposition.

Purpose of the Study:

  • To investigate microstructural WM alterations in PD patients with and without cognitive impairment.
  • To correlate WM changes with cognitive performance using R2* relaxometry and QSM.
  • To assess the potential of these MRI techniques for early detection of cognitive decline in PD.

Main Methods:

  • Recruited 24 PD patients with mild cognitive impairment (PD-MCI), 22 PD patients with normal cognition (PD-CN), and 19 healthy controls (HC).
  • Utilized brain MRI including T1-weighted and multi-echo gradient echo sequences for R2* and QSM analysis.
  • Performed voxel-based analysis of R2* values in WM and correlated findings with Montreal Cognitive Assessment (MoCA) scores.

Main Results:

  • PD-MCI patients showed lower R2* values in specific WM regions, such as the corpus callosum, compared to PD-CN and HC groups.
  • Quantitative susceptibility mapping (QSM) indicated no significant iron deposition in the WM across all participants.
  • A positive correlation was observed between R2* values and MoCA scores in WM regions, notably the corpus callosum and left hemisphere.

Conclusions:

  • R2* relaxometry effectively detects WM microstructural changes, indicative of demyelination and environmental alterations, in PD patients.
  • The absence of iron deposition in WM was confirmed by QSM.
  • These findings suggest R2* relaxometry combined with QSM holds promise for the early evaluation of cognitive decline in Parkinson's disease.

Related Concept Videos